DYSTROPHY MYOTONIC

Clinical trials for DYSTROPHY MYOTONIC explained in plain language.

Never miss a new study

Get alerted when new DYSTROPHY MYOTONIC trials appear

Sign up with your email to follow new studies for DYSTROPHY MYOTONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Experimental drug aims to control debilitating muscle disease

Disease control Ongoing

This global Phase 3 trial is testing whether an intravenous drug called AOC 1001 can help control symptoms of myotonic dystrophy type 1, a genetic muscle-wasting disease. About 159 adults with a confirmed diagnosis will receive either the drug or a placebo via infusion every 8 we…

Matched conditions: DYSTROPHY MYOTONIC

Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

DYSTROPHY MYOTONIC

Get alerted when new DYSTROPHY MYOTONIC trials appear

Experimental drug aims to control debilitating muscle disease